Nutrients

International journal of molecular sciences

plos medicine

Journal of medical Internet research

Medicina (Kaunas, Lithuania)

Studies in health technology and informatics

clinical and experimental pharmacology & physiology

Environmental monitoring and assessment

the american journal of the medical sciences

computer methods and programs in biomedicine

arthritis research & therapy

clinical therapeutics

expert opinion on therapeutic targets

lipids in health and disease

mutation research

advances in experimental medicine and biology

Chronobiology international

pediatric nephrology (berlin, germany)

Irish journal of medical science

Journal of translational medicine

Journal of global health

cardiorenal medicine

international journal of clinical pharmacy

blood purification

jama psychiatry

clinical microbiology and infection : the official publication of the european society of clinical microbiology and infectious diseases

Physiological reports

bmc nephrology

Kidney international

JCI insight

american journal of nephrology

indonesian journal of biotechnology

american journal of perinatology

expert opinion on pharmacotherapy

Kardiologiia

nephrology, dialysis, transplantation : official publication of the european dialysis and transplant association - european renal association

Nan fang yi ke da xue xue bao = Journal of Southern Medical University

journal of the american society of nephrology : jasn

oral diseases

expert opinion on investigational drugs

world journal of diabetes

learning health systems

Nephrology (Carlton, Vic.)

[1] Inverse correlation of kidney interstitial cells expansion with hemoglobin level and erythropoietin expression in single and repeated kidney ischemic/reperfusion injury in mice

[2] Chronic Kidney Disease and the Use of Social Media as Strategy for Health Education in Brazil.

[3] YouTube as a Source of Patient Information for Prenatal Repair of Myelomeningocele.

[4] Impact of urate-lowering drugs on the progression and recovery from chronic kidney disease among gout patients.

[5] Investigational hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHI) for the treatment of anemia associated with chronic kidney disease.

[6] Extracellular vesicles from human bone marrow mesenchymal stem cells repair organ damage caused by cadmium poisoning in a medaka model.

[7] Association between severe periodontitis and chronic kidney disease severity in pre-dialytic patients: A cross-sectional study.

[8] Apolipoprotein L1 (APOL1) risk variant toxicity depends on the haplotype background.

[9] APOL1 Kidney Risk Variants Induce Cell Death Mitochondrial Translocation and Opening of the Mitochondrial Permeability Transition Pore.

[10] Combining a gravitational search algorithm, particle swarm optimization, and fuzzy rules to improve the classification performance of a feed-forward neural network.

[11] Simultaneous angiotensin receptor blockade and glucagon-like peptide-1 receptor activation ameliorate albuminuria in obese insulin-resistant rats.

[12] Prevalence and determinants of type 2 diabetes among lean African migrants and non-migrants: the RODAM study.

[13] Distribution and management of the pediatric refugee population with renal replacement: A German pediatric cohort.

[14] Detecting Lifestyle Risk Factors for Chronic Kidney Disease With Comorbidities: Association Rule Mining Analysis of Web-Based Survey Data.

[15] Association of Patient Treatment Preference With Dropout and Clinical Outcomes in Adult Psychosocial Mental Health Interventions: A Systematic Review and Meta-analysis.

[16] Diabetic nephropathy in Africa: A systematic review.

[17] Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity.

[18] Symmetric dimethylarginine in dysfunctional high-density lipoprotein mediates endothelial glycocalyx breakdown in chronic kidney disease.

[19] EUCAST evaluation of 21 brands of Mueller-Hinton dehydrated media for disk diffusion testing.

[20] Serum Alkaline Phosphatase Level Predicts Cardiac Valve Calcification in Maintenance Hemodialysis Patients.

[21] Risk scores for predicting incident chronic kidney disease among rural Chinese people: a village-based cohort study.

[22] Preeclampsia and the Ten-Year Risk of Incident Chronic Kidney Disease.

[23] Data and knowledge standards for learning health: A population management example using chronic kidney disease.

[24] Renal Denervation: Physiology, Scope, and Current Evidence

[25] uremic cardiomyopathy: a new piece in the chronic kidney disease-mineral and bone disorder puzzle

[26] oral magnesium supplementation in chronic kidney disease stages 3 and 4: efficacy, safety, and effect on serum calcification propensity—a prospective randomized double-blinded placebo-controlled clinical trial

[27] intradialytic neuromuscular electrical stimulation improves functional capacity and muscle strength in people receiving haemodialysis: a systematic review

[28] prognostic abilities of different calculation formulas for the glomerular filtration rate in elderly chinese patients with coronary artery disease

[29] diabetic kidney disease: is there a non-albuminuric phenotype in type 2 diabetic patients?

[30] renal transplantation across abo barrier

[31] the impact of urate-lowering therapy on kidney function (impulskf)

[32] severe case of thrombotic microangiopathy with a delayed diagnosis of atypical haemolytic uraemic syndrome successfully managed with eculizumab

[33] remodeling of cardiovascular system and development of chronic kidney disease in patients with metabolic syndrome and obesity: role of genes enos, subunit p22-phox of nadph-oxidase and mthfr

[34] reduced baroreflex sensitivity, decreased heart rate variability with increased arterial stiffness in predialysis

[35] comparación entre las ecuaciones ckd-epi y mdrd para la estimación del filtrado glomerular en pacientes con enfermedad renal crónica

[36] clinicopathological correlation and treatment response of primary focal segmental glomerulosclerosis in adults and adolescents

[37] a qualitative research on the experience of haemodialysis in south karnataka: lived experience of persons undergoing haemodialysis

[38] renoprotective effect of pentoxifylline in advanced chronic kidney disease

[39] renoprotection and the bardoxolone methyl story - is this the right way forward a novel view of renoprotection in ckd trials: a new classification scheme for renoprotective agents

[40] does chronic kidney disease facilitate malignant myocardial fibrosis in heart failure with preserved ejection fraction of hypertensive origin?

[41] comparison of intradialytic parenteral nutrition with glucose or amino acid mixtures in maintenance hemodialysis patients

[42] kidney disease models: tools to identify mechanisms and potential therapeutic targets

[43] pth levels and not serum phosphorus levels are a predictor of the progression of kidney disease in elderly patients with advanced chronic kidney disease

[44] hypertension control, apparent treatment resistance, and outcomes in the elderly population with chronic kidney disease

[45] the association of daily activity levels and estimated kidney function in men and women with predialysis chronic kidney disease

[46] repeated serum creatinine measurement in primary care: not all patients have chronic renal failure

[47] association of chronic kidney disease with small vessel disease in patients with hypertensive intracerebral hemorrhage

[48] the oxford classification predictors of chronic kidney disease in pediatric patients with iga nephropathy

[49] prevalence of vitamin d deficiency in different groups of chronic renal failure patients.

[50] a reduced set of features for chronic kidney disease prediction

[51] cardiac resynchronization therapy prevents progression of renal failure in heart failure patients

[52] renin-angiotensin system antagonists, glomerular filtration rate and blood pressure

[53] anti-parathyroid treatment effectiveness and persistence in incident haemodialysis patients with secondary hyperparathyroidism

[54] editorial: hypoxia in kidney disease

[55] lipidomic signature of progression of chronic kidney disease in the chronic renal insufficiency cohort

[56] efeitos da abordagem interdisciplinar na qualidade de vida e em parâmetros laboratoriais de pacientes com doença renal crônica quality of life and improvement of laboratory parameters as an outcome of an interdisciplinary approach to the care of patients with chronic kidney disease

[57] angiotensin-converting enzyme inhibitors and receptor blockers in heart failure and chronic kidney disease – demystifying controversies

[58] spanish multicentre pibhe study: prevalence and immunisation of chronic hepatitis b in haemodialysis patients in spain

[59] exploring sleep disorders in patients with chronic kidney disease

[60] renal biopsy in paroxysmal nocturnal hemoglobinuria: an insight into the spectrum of morphologic changes

[61] factors influencing access to education, decision making, and receipt of preferred dialysis modality in unplanned dialysis start patients

[62] the effect of some medications given to ckd patients on vitamin d levels

[63] transplante renal em pacientes infectados pelo hiv kidney transplantation in hiv infected patients

[64] cathepsin s as an inhibitor of cardiovascular inflammation and calcification in chronic kidney disease

[65] the prevalence of chronic kidney disease in patients with acute coronary syndrome

[66] protein energy wasting in chronic kidney disease: an update with focus on nutritional interventions to improve outcomes

[67] estimated glomerular filtration rate (egfr): a serum creatinine-based test for the detection of chronic kidney disease and its impact on clinical practice

[68] association of sleep duration, symptoms, and disorders with mortality in adults with chronic kidney disease

[69] autosomal dominant polycystic disease is associated with depressed levels of soluble tumor necrosis factor-related apoptosis-inducing ligand

[70] managing pregnancy in chronic kidney disease: improving outcomes for mother and baby

[71] detection of cardiovascular calcifications: is it a useful tool for nephrologists?

[72] reduced kidney levels of lysophosphatidic acids in rats after chronic administration of aristolochic acid: its possible protective role in renal fibrosis

[73] the use of statin drugs in patients with chronic kidney disease, combined with dyslipidemia

[74] patient-reported outcomes in patients with chronic kidney disease and kidney transplant—part 1

[75] prevalência da doença renal crônica nos estágios 3, 4 e 5 em adultos prevalence of chronic kidney disease, stages 3, 4 and 5 in adults

[76] the use of skeletonized internal mammary artery for coronary artery bypass grafting

[77] classificação em estágios da doença renal crônica em cães e gatos: abordagem clínica, laboratorial e terapêutica classification into stages of chronic kidney disease in dogs and cats: clinical, laboratorial and therapeutic approach

[78] non-invasive renal perfusion imaging using arterial spin labeling mri: challenges and opportunities

[79] is fibroblast growth factor 23 the leading cause of increased mortality among chronic kidney disease patients? a narrative review

[80] renin-angiotensin system inhibitors reduce serum asymmetric dimethylarginine levels and oxidative stress in normotensive patients with chronic kidney disease

[81] gut microbiota in chronic kidney disease

[82] urinary calcium excretion and risk of chronic kidney disease in the general population

[83] estimating glomerular filtration rates in elderly chinese patients with chronic kidney disease: performance of six modified formulae developed in asian populations

[84] an unusual case of cocoon abdomen in a patient on hemodialysis

[85] Hypokalemia, Its Contributing Factors and Renal Outcomes in Patients with Chronic Kidney Disease

[86] What are the anticoagulation options for intermittent hemodialysis? - Nature Reviews Nephrology

[87] Sugar-sweetened beverage consumption and risk of incident chronic kidney disease: Tehran lipid and glucose study.

[88] Net clinical benefit analysis of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and chronic kidney disease: Protocol for a systematic review and meta-analysis

[89] Prevalence and predictors of left ventricular dysfunction among patients with chronic kidney disease attending Muhimbili National Hospital in Tanzania — a cross-sectional study

[90] Urinary Uromodulin Levels and UMOD Variants in Black South Africans with Hypertension-Attributed Chronic Kidney Disease

[91] Prevalence and Predictors of Chronic Kidney Disease in a Semiurban Community in Lagos

[92] Prevalence and predictors of left ventricular dysfunction among patients with chronic kidney disease attending Muhimbili National Hospital in Tanzania — a cross-sectional study

[93] Study of Evidences on Chronic Kidney Disease Due to Unknown Etiology Based on Environmental, Social, Economic and Health Patterns of Selected Population: A Case Study Done at Wilgamuwa Area

[94] Insulin Glargine U100 Improved Glycemic Control and Reduced Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3 and 4.

[95] Determination of genotoxic effects in hemodialysis patients with chronic kidney disease and the role of diabetes mellitus and other biochemical parameters.

[96] Serum 1,5-Anhydroglucitol Concentrations Remain Valid as a Glycemic Control Marker in Diabetes with Earlier Chronic Kidney Disease Stages

[97] Prevalence and Disease Burden of Chronic Kidney Disease.

[98] Primary care physicians' perceptions of barriers and facilitators to management of chronic kidney disease: A mixed methods study.

[99] Diagnostic potential of simplified methods for measuring glomerular filtration rate to detect chronic kidney disease in dogs.

[100] Optimal Blood Pressure in Patients With Coronary Artery Disease and Chronic Kidney Disease: HIJ-CREATE Substudy.

[101] Metabolic acidosis in chronic kidney disease: The nutritional approach